Company: FCRX
Filing Date: 2025-02-19
Form Type: 10-K
Source: 0000950170-25-023153
Chunk: 343

Company: Crescent Capital BDC, Inc.
Filing Date: 2025-02-19
Form: 10-K
Item: Item 1B
Chunk 343
---
 deferred financing costs of $8,214 and $7,138, respectively)
    $
    875,837

    $
    844,783

    Distributions payable
     
    15,566

    15,195

    Interest and other debt financing costs payable
     
    10,408

    10,900

    Management fees payable
     
    5,066

    5,026

    Incentive fees payable
     
    4,305

    4,770

    Deferred tax liabilities
     
    746

    578

    Unrealized depreciation on foreign currency forward contracts
     
    —

    84

    Accrued expenses and other liabilities
     
    3,709

    3,449

    Total liabilities
     
    915,637

    884,785

    Commitments and Contingencies (Note 8)

    Net assets

    Preferred stock, par value $0.001 per share (10,000 shares authorized, zero outstanding, respectively)
     
    —

    —

    Common stock, par value $0.001 per share (200,000,000 shares authorized, 37,061,547 shares issued and outstanding)
     
    37

    37

    Paid-in capital in excess of par value
     
    959,098

    965,895

    Accumulated earnings (loss)
     
    (218,498
    )

    (223,338
    )

    Total net assets
     
    740,637

    742,594

    Total liabilities and net assets
    $
    1,656,274

    $
    1,627,379

    Net asset value per share
    $
    19.98

    $
    20.04

See accompanying notes

71

Crescent Capital BDC, Inc. 

Consolidated Statements of Operations

(in thousands, except share and per share data)

    For the years ended December 31,

    2024

    2023

    2022

    Investment Income:

    From non-controlled non-affiliated investments:

    Interest income

    $
    166,912

    $
    162,089

    $
    101,751

    Paid-in-kind interest

    9,592